ESSA Pharma
EPIX
EPIX was delisted on the 8th of October, 2025.
10 hedge funds and large institutions have $26.4M invested in ESSA Pharma in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
14.52% more ownership
Funds ownership: 0% → 14.52% (+15%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$13M |
| 2 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$7.61M |
| 3 |
AIC
AWM Investment Company
New York
|
+$5.08M |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$2.01M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.59M |
Top Sellers
EPIX Hedge Fund Activity: Q3 2015 in Review
10 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in ESSA Pharma (EPIX) for Q3 2015, worth a combined $26.4M.
Buyers outnumbered sellers: 10 funds opened new EPIX positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $13M.
- 10 institutional investors held ESSA Pharma (EPIX) as of Q3 2015, up from 0 in Q2 2015.
- Funds reported $26.4M of ESSA Pharma stock for Q3 2015.
- 10 funds opened new ESSA Pharma positions in Q3 2015 and 0 closed out, a net change of +10 holders.
- The largest ESSA Pharma buyer in Q3 2015 was Deerfield Management, an estimated $13M added.
Based on aggregated 13F filings for Q3 2015.